[Risk of infection in untimely rupture of fetal membranes].
D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D002585:Cesarean Section; D002821:Chorioamnionitis / Q000209:etiology*; D005260:Female; D005322:Premature Rupture of Fetal Membranes / Q000150:complications*; D005323:Fetal Monitoring; D005831:Genital Diseases, Female / Q000150:complications; D006801:Humans; D007231:Infant, Newborn; D011247:Pregnancy; D011292:Premedication; D011645:Puerperal Infection / Q000209:etiology; D012306:Risk; D012749:Sexually Transmitted Diseases / Q000150:complications; D013530:Surgical Wound Infection / Q000209:etiology
D000900:Anti-Bacterial Agents
Infektionsrisiken bei unzeitigem Blasensprung.